Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It should be discontinued at least two months before planned conception due to its long half-life
Every patient receives an 80+ biomarker lab panel before starting to check for thyroid dysfunction, insulin resistance, and hormone imbalances that could be contributing to weight gain independently
Ro's approach also signals how the conversation around GLP-1s is becoming more mainstream
Research Applications & Usage Information IGF-1 LR3 (1 mg) is commonly incorporated into laboratory and preclinical research involving: IGF-1 receptor activation and binding affinity studies Myoblast and muscle cell culture experiments Cellular proliferation and differentiation assays Protein synthesis and anabolic signaling research Intracellular signaling pathway analysis (e.g., PI3K/Akt, MAPK/ERK) Comparative evaluation of native IGF-1 versus long-acting analogs Metabolic regulation and glucose-uptake research models Tissue growth and regenerative pathway investigations All applications are investigational and limited to in vitro or preclinical research settings
Reviews have proposed that GLP-1 signaling, changes in adipose-derived stem cells, oxidative stress, and dermal remodeling could affect collagen support and skin architecture beyond the mechanical loss of facial fat
